GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ENCell Co Ltd (XKRX:456070) » Definitions » Price-to-Funds-From-Operations

ENCell Co (XKRX:456070) Price-to-Funds-From-Operations : (As of May. 02, 2025)


View and export this data going back to 2024. Start your Free Trial

What is ENCell Co Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


ENCell Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
701 Yeongdong-daero, 11th floor, Gangnam-gu, Seoul, KOR
ENCell Co Ltd is a biopharmaceutical company. The company is engaged in conducting biopharmaceutical contract development and manufacturing (CDMO) service business and cell, gene therapy new drug development business for rare/incurable muscle diseases such as Charcot-Marie-Tooth disease, Duchenne muscular dystrophy, and sarcopenia.